Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure.

Frange P, Briand N, Avettand-fenoel V, Veber F, Moshous D, Mahlaoui N, Rouzioux C, Blanche S, Chaix ML.

Pediatr Infect Dis J. 2011 Aug;30(8):684-8. doi: 10.1097/INF.0b013e31821752d6.

PMID:
21427626
2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
4.

Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.

Humphreys EH, Chang LW, Harris J.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD006517. doi: 10.1002/14651858.CD006517.pub3. Review.

PMID:
20556768
5.

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.

Sigaloff KC, Calis JC, Geelen SP, van Vugt M, de Wit TF.

Lancet Infect Dis. 2011 Oct;11(10):769-79. doi: 10.1016/S1473-3099(11)70141-4. Epub 2011 Aug 25. Review.

PMID:
21872531
6.

[The "induction-maintenance" strategy].

Arribas López JR.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:8-11. Review. Spanish.

PMID:
19572438
7.

Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease.

Wainberg MA, Martinez-Cajas JL.

Infect Disord Drug Targets. 2009 Apr;9(2):172-90. Review.

PMID:
19275705
8.

[Lopinavir/ritonavir in new initial antiretroviral treatment strategies].

Rolón MJ, Figueroa MI, Sued O, Cahn P.

Enferm Infecc Microbiol Clin. 2014 Nov;32 Suppl 3:7-11. doi: 10.1016/S0213-005X(14)70161-2. Review. Spanish.

PMID:
25542869
9.

Antiretroviral therapy in children: recent advances.

Lodha R, Manglani M.

Indian J Pediatr. 2012 Dec;79(12):1625-33. doi: 10.1007/s12098-012-0903-9. Epub 2012 Nov 27. Review.

PMID:
23184329
10.

HIV exposure through contact with body fluids.

[No authors listed]

Prescrire Int. 2012 Apr;21(126):100-1, 103-5. Review.

PMID:
22515138
11.

[Efficacy of initial antiretroviral therapy based on lopinavir/ritonavir plus 2 nucleoside/nucleotide analogs in patients with human immunodeficiency virus type 1 infection].

Zamora L, Gatell JM.

Enferm Infecc Microbiol Clin. 2014 Nov;32 Suppl 3:2-6. doi: 10.1016/S0213-005X(14)70160-0. Review. Spanish.

PMID:
25542868
12.

Protease inhibitors as preferred initial regimen for antiretroviral-naive HIV patients.

Tejerina F, Bernaldo de Quirós JC.

AIDS Rev. 2011 Oct-Dec;13(4):227-33. Review.

PMID:
21975358
13.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.

PMID:
18677028
14.

State of the Art of Dual Therapy in 2015.

Nozza S, Svicher V, Saracino A, d'Ettorre G, De Luca A, Maggiolo F, Bonora S, di Biagio A, Rusconi S, Mussini C.

AIDS Rev. 2015 Jul-Sep;17(3):127-34. Review.

PMID:
26450801
15.

Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection.

Menéndez-Arias L, Alvarez M.

Antiviral Res. 2014 Feb;102:70-86. doi: 10.1016/j.antiviral.2013.12.001. Epub 2013 Dec 15. Review.

PMID:
24345729
16.

Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.

Penazzato M, Dominguez K, Cotton M, Barlow-Mosha L, Ford N.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S177-81. doi: 10.1093/cid/civ110. Review.

PMID:
25972500
17.

Antiretroviral therapy in treatment-naïve patients with HIV infection.

Camacho R, Teófilo E.

Curr Opin HIV AIDS. 2011 Dec;6 Suppl 1:S3-11. doi: 10.1097/01.COH.0000410239.88517.00. Review.

PMID:
22156777
18.

Management of HIV infection after triple class failure.

Cossarini F, Spagnuolo V, Gianotti N, Carbone A, Lazzarin A, Castagna A.

New Microbiol. 2013 Jan;36(1):23-39. Epub 2013 Jan 1. Review.

19.

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.

Sierra-Aragón S, Walter H.

Intervirology. 2012;55(2):84-97. doi: 10.1159/000331995. Epub 2012 Jan 24. Review.

20.

Obstacles to successful antiretroviral treatment of HIV-1 infection: problems & perspectives.

Potter SJ, Chew CB, Steain M, Dwyer DE, Saksena NK.

Indian J Med Res. 2004 Jun;119(6):217-37. Review.

PMID:
15243161

Supplemental Content

Support Center